Company Filing History:
Years Active: 2012-2014
Title: The Innovations of Marc J C Scanio
Introduction
Marc J C Scanio is an accomplished inventor based in Lindenhurst, IL (US). He has made significant contributions to the field of neuroscience through his innovative patents. With a total of 4 patents, Scanio's work focuses on developing compounds that interact with neuronal nicotinic receptors.
Latest Patents
One of his latest patents is titled "Selective substituted pyrazine ligands for neuronal nicotinic receptors." This application describes selective ligands of formula (I) for neuronal nicotinic receptors (NNRs), specifically targeting the α4β2 NNR subtype. The patent outlines the compositions and methods of using these ligands, with specific definitions provided in the specification. Another notable patent is "Aminomethyl azaadamantane derivatives and methods of use thereof." This invention relates to compounds that are substituted aminomethyl azaadamantane derivatives, along with the compositions and methods for their use.
Career Highlights
Throughout his career, Marc J C Scanio has worked with prominent companies in the pharmaceutical industry, including Abbott Laboratories Corporation and AbbVie Inc. His experience in these organizations has contributed to his expertise in developing innovative solutions in drug design and development.
Collaborations
Scanio has collaborated with notable colleagues such as William H Bunnelle and Lei Shi. These partnerships have further enhanced his research and development efforts in the field.
Conclusion
Marc J C Scanio's contributions to the field of neuroscience through his patents and collaborations highlight his innovative spirit and dedication to advancing medical science. His work continues to impact the development of new therapeutic compounds.